Remove 2025 Remove Communication Remove Compounding
article thumbnail

Connected customer data: a golden opportunity for pharma marketers

pharmaphorum

Approximately 30% of global data volume is generated by the healthcare industry and it will continue to expand with a compound annual growth rate predicted to reach 36% by 2025, according to research by RBC Capital Markets.

article thumbnail

Customer Relationship Management in Healthcare Industry: Features, Benefits, and Specifics

Viseven

billion by 2025 , with a compound annual growth rate (CAGR) growth of more than 9%. It helps to organize communication processes, keep track of operational activities, and see what works in your management approaches and what requires changes in the current health system. Let’s go. What does CRM stand for in Healthcare?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Influence of 5G on Healthcare

Viseven

Although 5G is currently limited to large cities in developed countries, by around 2025, we can expect its reach will extend beyond the urban areas. As this trend unfolds, it is vital to understand the benefits 5G brings, how it impacts healthcare communication , and how healthcare businesses can leverage it. What Is 5G?

article thumbnail

Why demand is rising for secure and climate-controlled gene therapy services

Pharmaceutical Technology

Further compounding the complexity is the highly temperature-sensitive nature of these products, meaning any hiccup faced when processing products outside of their freezer banks can have a serious, knock-on effect. You have very little room for error and need to leverage partners with the expertise and attention to detail to ensure success.

article thumbnail

Quality first: How pharma can meet injectables demand while staying compliant

Pharmaceutical Technology

From 2025, it will be substituted with a new chapter on functional tests for the complete system.” When it comes to highly sensitive large-molecule drugs, sourcing premium elastomeric components with a cleaner compound, such as Datwyler’s FM457, is an essential step in reducing the E&L risk.

article thumbnail

High biologics demand spurs need for greater contract manufacturing

Pharmaceutical Technology

Meanwhile, the Indian biologics market is expected to grow to $12 billion by 2025, with a compound annual growth rate (CAGR) of 22%. China’s Ministry of Science and Technology set a goal that by 2020, 4% of the country’s gross domestic product (GDP) should be used to develop the biotechnology sector.

article thumbnail

From wellness to wealth: How Gen Y, Gen Z, and AI are driving mission $100 billion for India’s nutraceutical future

Express Pharma

Currently valued at USD 4-5 billion, this sector is expected to reach USD 18 billion by 2025 (Source: Invest India). billion in 2020, is set to grow at a compound annual growth rate (CAGR) of 21.79 Bolstered by rising health awareness and increasing disposable incomes, this sector is emerging as a global contender. billion by 2026.